AHK14	A/Hong Kong/4801/2014
BLI	biolayer interferometry
bnAbs	broadly neutralizing antibodies
CAE	competitive antibody equivalents
CDR	complementary determining region
Fab	antigen binding fragment
FACS	fluorescence-activated cell sorting
HA	hemagglutinin
HAI	hemagglutinin inhibition
HC	heavy chain
HD	high dose
LC	light chain
LOD	limit of detection
mAb	monoclonal antibody
MOI	multiplicity of infection
NIV	nanoparticle influenza vaccine
NP	nanoparticle
PBMC	peripheral blood mononuclear cell
RBS	receptor binding site
Sf9	Spodoptera frugiperda cells
TEM	transmission electron microscopy
tNIV	trivalent nanoparticle influenza vaccine
VE	vestigial esterase
VL	variable light
WHO	World Health Organization
WT	wild-type